HPV vaccination is one of the effective methods to prevent HPV infection. Yesterday morning, the first domestic nine-valent HPV vaccine was administered in Shenzhen. Mothers and working women came to the Longhua District Maternal and Child Health Hospital vaccination clinic, becoming the first group of women in Shenzhen to receive the domestic nine-valent HPV vaccine.
Cervical cancer is one of the most common malignant tumors in women and currently the only cancer that can be prevented through vaccination. Getting vaccinated against HPV early can effectively reduce the risk of viral infection.
In May this year, China’s first domestic nine-valent HPV vaccine was officially approved for market by the National Medical Products Administration. Clinical data show that the domestic nine-valent HPV vaccine has comparable immune response and safety to imported products. The domestic nine-valent HPV vaccine is suitable for women aged 9-45, covering two peak periods of HPV infection in Chinese women: under 25 years old and 40-44 years old.
The domestic nine-valent HPV vaccine covers 9 types of HPV, including 7 high-risk types. The two-dose regimen has been expanded to include 17-year-olds (one dose at 0 and 6 months), allowing girls aged 9-17 to receive one less dose; women aged 18-45 need three doses (one dose at 0, 1, and 6 months).
The domestic nine-valent HPV vaccine costs 520 yuan per dose (499 yuan for the vaccine and 21 yuan for administration).
Women aged 9-45 can receive the HPV vaccine. Early vaccination provides early protection, with special focus needed on girls aged 9-14. First-year middle school girls in Guangdong Province can receive HPV vaccination for free.
The domestic nine-valent HPV vaccine is now available in Shenzhen. Women who need vaccination can make appointments through official WeChat accounts or consult at community health centers with vaccination services.
